WuXi Pharmatech (Cayman) Inc (NYSE:WX)
| 20.89 Data as of May 22 |  +0.16 / +0.77%Today’s Change | 13.00 Today|||52-Week Range 21.29 | +32.63% Year-to-Date |
Latest WX News | Press Releases
| WuXi PharmaTech Beats on Both Top and Bottom Lines May 15 / MotleyFool.com | Good News for Cubist Pharmaceuticals - Analyst Blog May 09 / Zacks.com |
| Wider-than-Expected Loss at ChemoCentryx - Analyst Blog May 14 / Zacks.com | Narrower-than-Expected Loss at ArQule - Analyst Blog May 09 / Zacks.com |
| Dendreon Narrows 1Q Loss - Analyst Blog May 10 / Zacks.com |
Today’s Trading
| Previous close | 20.73 |
| Today’s open | 20.70 |
| Day’s range | 20.53 - 21.29 |
| Volume | 399,338 |
| Average volume (3 months) | 347,890 |
| Market cap | $1.5B |
| Dividend yield | -- |
Data as of 4:01pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | +7.15% |
| Earnings growth (this year) | +9.36% |
| Earnings growth (next 5 years) | +11.53% |
| Revenue growth (last year) | +22.78% |
| P/E ratio | -- |
| Price/Sales | 2.24 |
| Price/Book | 2.51 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNTSSantarus Inc | -0.02 | -0.09% |
| IRWDIronwood Pharmaceuti... | -0.58 | -4.30% |
| AKRXAkorn Inc | -0.28 | -1.89% |
| NPSPNPS Pharmaceuticals ... | +0.42 | +2.89% |
Data as of 4:00pm ET, 05/22/2013
Financials
| Last reporting date | May 14, 2013 |
| EPS forecast (this quarter) | $0.35 |
| Annual revenue (last year) | $499.9M |
| Annual profit (last year) | $86.6M |
| Net profit margin | 17.32% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Chief Executive Officer Ge Li, PhD |
Chief Operating & Financial Officer Edward Hu, MBA |
Corporate headquarters Shanghai, Shanghai |
Forecasts
